Discover 1,141 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,141
Active & Responsive
Open-Label Psilocybin Study in Transdiagnostic Population
for
Transdiagnostic, Depression - Major Depressive Disorder,
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT06442423
Phase1, Recruiting
Active & Responsive
SV2 PET Imaging With [11C]APP311
for
Schizophrenia and Other Psychotic Disorders,
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 70+
Code: NCT03995121
Recruiting
Active & Responsive
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
for
Obsessive-Compulsive Disorder
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 65
Code: NCT04131829
Phase1, Phase2, Recruiting
Active & Responsive
Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)
for
Polycystic Ovarian Syndrome in Adolescent Females,
Location: New Haven CT
Sponsor: Yale University
Sex: Female
Age: 13 - 21
Code: NCT04355572
Recruiting
Active & Responsive
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
for
Bipolar Disorder Type I With Mania
Location: New Haven CT, Staten Island NY, Marlton NJ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT06929273
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: New Haven CT, White Plains NY, Albany NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase3, Recruiting
Active & Responsive
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
for
Glioblastoma
Location: New Haven CT, New York NY, Boston MA, Montreal, Toronto,
Sponsor: Global Coalition for Adaptive Research
Sex: All
Age: 18+
Code: NCT03970447
Phase2, Phase3, Recruiting
Active & Responsive
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
for
Major Depressive Disorder (MDD), Depression in Adults,
Location: New Haven CT, New York NY, Boston MA, Watertown NY,
Sponsor: Cybin IRL Limited
Sex: All
Age: 18 - 70+
Code: NCT06793397
Phase3, Recruiting
Active & Responsive
A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA)
for
AML, MDS
Location: New Haven CT, Hackensack NJ, New York NY, Boston MA,
Sponsor: TScan Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05473910
Phase1, Recruiting
Active & Responsive
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
for
Intracranial Aneurysm
Location: New Haven CT, Stony Brook NY, New York NY, Albany NY,
Sponsor: Medtronic Neurovascular Clinical Affairs
Sex: All
Age: 18 - 70+
Code: NCT02998229
Recruiting
Active & Responsive
Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)
for
Diabetes Mellitus, Type 2
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 60
Code: NCT05776563
Recruiting
Active & Responsive
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: New Haven CT, Springfield MA, Valhalla NY, The Bronx NY,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05338697
Recruiting
Active & Responsive
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
for
Anemia, Sickle Cell, Healthy Volunteers
Location: New Haven CT, Boston MA, Philadelphia PA, Fairfax VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06481306
Phase1, Phase2, Recruiting
Active & Responsive
A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma